Category: Legislative

Congress Turns House Floor to 340B For an Hour

June 9, 2022 Tom Mirga, Editor at Large Views

C-SPAN screenshot of Rep. Abigail Spanberger (D-VA) speaking on the House floor

Rep. Abigail Spanberger (D-Va.) organized an hour's worth of testimonials for 340B Tuesday night on the U.S. House floor.

Seven U.S. representatives—five Democrats and two Republicans—lauded the 340B program on the House floor Tuesday night during an hour of speeches organized by Rep. Abigail Spanberger (D-Va.) and co-hosted by Rep. John Rose (R-Tenn.).

The event was postponed twice before

…

GlaxoSmithKline Ending Voluntary 340B Pricing on Two Orphan Drugs

June 7, 2022 Tom Mirga, Editor at Large Views

GlaxoSmithKline is ending voluntary 340B pricing for rural and cancer hospitals on its blockbuster severe asthma drug Nucala and first-line advanced ovarian cancer drug Zejula.

In a blow to rural and cancer hospitals, U.K. drug manufacturer GlaxoSmithKline (GSK) is ending voluntary 340B pricing for them on its blockbuster severe asthma drug Nucala and first-line advanced ovarian cancer drug Zejula.

Drug wholesaler AmerisourceBergen recently posted a

…

340B Report Publisher and CEO: Momentum for 340B Protections Is Growing

June 3, 2022 Tom Mirga, Editor at Large Views

Interior of Washington State House of Representatives chamber

340B healthcare providers have turned to the states to address challenges to the drug discount program, 340B Report Publisher and CEO Ted Slafsky says.

Safety net healthcare providers increasingly have turned to the states to address challenges to the 340B program, 340B Report Publisher and CEO Ted Slafsky says in his latest column for medication management solutions company Omnicell.

“In just four years, an

…

With Talk of Legislation Heating Up, PhRMA Seeks a New 340B Policy Director

May 26, 2022 Tom Mirga, Editor at Large Views

PhRMA is seeking a new director for its policy and research team to help develop and lead implementation of work on 340B.

Pharmaceutical Research and Manufacturers of America (PhRMA) is seeking a new director for its policy and research team to help develop and lead implementation of work on 340B and related hospital cost and affordability issues, according to an employment solicitation

…

Maryland Governor Signs 340B Anti-discrimination Bill into Law

May 26, 2022 Tom Mirga, Editor at Large Views

Maryland Gov. Larry Hogan (R) signing a document

Maryland Gov. Larry Hogan (R) has signed legislation barring PBM discrimination against 340B covered entities and contract pharmacies.

Maryland Gov. Larry Hogan (R) has signed legislation prohibiting pharmacy benefit manager (PBM) discrimination against 340B covered entities and their contract pharmacies.

Hogan signed HB 1274 into law on May 16. It takes effect Oct. 1. The state House and Senate

…

In What Would Be the Only Second State to Enact Such Legislation, Calif. Senate Votes to Shield 340B Providers from Manufacturers and PBMs’ Actions

May 24, 2022 Tom Mirga, Editor at Large Views

The California Senate passed legislation to bar drug manufacturer conditions on covered entities’ 340B drug purchases and to bar pharmacy benefit manager (PBM) discrimination against 340B covered entities and their pharmacies.

The California Senate passed legislation yesterday to prohibit drug manufacturer conditions on covered entities’ 340B drug purchases and to prohibit pharmacy benefit manager (PBM) discrimination against 340B covered entities and their pharmacies.

The Senate voted 24-9 in favor of SB-939 and

…

State Bill That Would Have Stopped Drug Industry from Imposing 340B Contract Pharmacy Restrictions Dies

May 19, 2022 Tom Mirga, Editor at Large Views

A 340B anti-discrimination bill targeting pharmacy benefit managers and drug manufacturers failed to advance in Connecticut.

Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on May 4.

…

Colorado Lawmakers Pass 340B Anti-discrimination Bill

May 19, 2022 Tom Mirga, Editor at Large Views

Colorado lawmakers voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

The Colorado General Assembly has voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

Gov. Jared Polis (D) is expected to sign the bill, HB22-1122. He

…

340B Providers Lose their Biggest GOP Ally in U.S. House

May 12, 2022 Tom Mirga and Ted Slafsky, Editor at Large Views

U.S. Rep. David McKinley (R-WA) gestures during hearing

U.S. Rep. David McKinley (R-W.Va.) lost his GOP primary election this week. It's a huge blow for 340B entities that have relied on his help in Congress for years.

In a major blow to the 340B provider community, U.S. Rep. David McKinley, the leading voice for the 340B program in the House Republican caucus, was defeated Tuesday in the West Virginia Republican primary. McKinley will remain in office until

…

Drug Makers Ask Michigan Lawmakers to Erase Section from New 340B State Law

May 12, 2022 Tom Mirga, Editor at Large Views

Michigan 340B hospitals say drug manufacturers are lobbying state lawmakers to erase language from a new state law that the hospitals say stops the drug makers from imposing claims submission requirements as a condition for 340B pricing.

Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B

…

Site Footer Live